Skip to main content

Patient centered questions MCQs for assessment of "Clinical problem solving and Medical decision (62M)

A 62-year-old male with a history of long-standing diabetes mellitus and hypertension presented to the outpatient department with complaints of exertional shortness of breath and pedal edema since three years. He also complains of intermittent claudication of both lower limbs after walking for around 250 meters since last three years with improvement upon standing for a few minutes. He also complains of episodes of dizziness after walking and has been noted to have a regular daytime somnolence with nocturnal apneic episodes and snoring. He also complained of sudden diminished vision of one eye three months back.  

The general examination reveals a large central obesity and bilateral pedal edema along with hyperpigmentation of the skin and "peau de orange." His BMI is 34 kg/m2. 

On investigations, his pulmonary function test and 2D Echo and an adenosine driven thallium perfusion scan turn out to be normal. His Hb is 8g % with microcytic hypochromic anemia with reduced serum iron, reduced transferrin saturation and TIBC with normal serum ferritin. His serum creatinine is 1.9 mg % and his urine 24 hour protein excretion is around 2 g%. A polysomnography was done earlier. 

Which of the following parameter in the polysomnogram will likely be helpful in the management of his nighttime choking? 
  1. Pulmonary arterial O2 saturation
  2. Respiratory rate
  3. Apnea-hypopnea index
  4. Lower limb arterial doppler study
  5. Coronary angiogram





A 62-year-old male with a history of long standing diabetes mellitus and hypertension presented to the outpatient department with complaints of exertional shortness of breath and pedal edema since three years. He also complains of intermittent claudication of both lower limbs after walking for around 250 meters since last three years with improvement upon standing for a few minutes. He also complains of episodes of dizziness after walking and has been noted to have a regular daytime somnolence with nocturnal apneic episodes and snoring. 

The general examination reveals a large central obesity and bilateral pedal edema along with hyperpigmentation of the skin and "peau de orange." His fundoscopy revealed a recovering vitreous hemorrhage with proliferative diabetic retinopathy. 

On investigations, his pulmonary function test and 2D Echo and an adenosine driven thallium perfusion scan turn out to be normal. His Hb is 8g % with microcytic hypochromic anemia with reduced serum iron, reduced transferrin saturation and TIBC with normal serum ferritin. His serum creatinine is 1.9 mg % and his urine 24 hour protein excretion is around 2 g%. His blood sugar profile is controlled on insulin glargine at night and bolus insulin thrice before meals. His Hba1c is 6.5. A sleep study showed multiple episodes of sleep apnoea during REM sleep and Doppler examination of lower limbs revealed normal arterial flow. His polysomniogram reports reveal apnea-hyponea index of 47. 

Which of the following is the best next step in the management of this patient? 

  1. Continuous positive airway pressure
  2. Reassurance 
  3. Only weight loss
  4. Surgical correction 
  5. Only positional therapy   

A 62-year-old male with a history of long standing diabetes mellitus and hypertension presented to the outpatient department with complaints of exertional shortness of breath and pedal edema since three years. He also complains of intermittent claudication of both lower limbs after walking for around 250 meters since last three years with improvement upon standing for a few minutes. He also complains of episodes of dizziness after walking and has been noted to have a regular daytime somnolence with nocturnal apneic episodes and snoring. 

The general examination reveals a large central obesity and bilateral pedal edema along with hyperpigmentation of the skin and "peau de orange." His fundoscopy revealed a recovering vitreous hemorrhage with proliferative diabetic retinopathy. 

On investigations, his pulmonary function test and 2D Echo and an adenosine driven thallium perfusion scan turn out to be normal. His Hb is 8g % with microcytic hypochromic anemia with reduced serum iron, reduced transferrin saturation and TIBC with normal serum ferritin. His serum creatinine is 1.9 mg % and his urine 24 hour protein excretion is around 2 g%. His blood sugar profile is controlled on insulin glargine at night and bolus insulin thrice before meals. His Hba1c is 6.5. A sleep study showed multiple episodes of sleep apnoea during REM sleep and Doppler examination of lower limbs revealed normal arterial flow. 

Which of the following is the best next step in the management of this patient? 



  1. Exercise
  2. Restricting fluid intake
  3. Cilostazol
  4. Amlodipine
  5. Stenting 

Comments

Popular posts from this blog

55 years Old male with Bipolar affected disorder moving from depression to Manic to depression phase

Disclaimer:- This is a HIPAA de-identified open-online-patient-record with initial information in patient's voice, posted here December 2017 after collecting informed patient consent (form downloadable Click Here) This is a case of a 55 years old, diabetic, hypertensive patient who was diagnosed with Bipolar affected disorder since 1995. In 1995 due to financial loss he was attacked by this condition. He was seen by Dr. D. K Agarwala and diagnosed as BPAD-Depression phase and treated with lithium, sodium valporate, propranolol, Zeptol cr, Nitrosum - S.  With the treatment he was reasonably well but every 6 months of interval he appeared to have some disturbance like didn't want to talk to anybody, forgot to smile etc. They went to the doctor and treated accordingly and was continuing the treatment.  In the year of 2013, August he was diagnosed with BPAD-severe depression phase but, he was not responding well to the medications and then they went to NIMHANS for

Consent Forms

Hindi BMJ Consent form   Bengali BMJ Consent form English BMJ Consent form   Telegu BMJ Consent Form Telegu BMJ Consent Form   UDHC Consent Form                

drugs to avoid or use in terms of their pregnancy category

The optimal AEDs therapy of women with epilepsy who are of childbearing age is unclear because of a lack of conclusive data on the comparative teratogenicity of different antiseizure drugs and no antiepileptic drug has proven safe in pregnancy in terms of teratogenesis. Data on the comparative efficacy of various antiseizure drugs for controlling seizures during pregnancy are also quite limited, and there are no randomized trials in this setting. Treatment must be individualized for all patients. Women with epilepsy are classified as high risk during pregnancy and as there are no clear data indicating that any drug is without risk in pregnancy therefore, the antiseizure drug regimen should be optimized six months prior to planned conception.  Choice of antiepileptic drugs in women of childbearing age and  pregnant women with epilepsy:  1. T he antiseizure drug that stops seizures in a given patient is the one that should be used with an exception of valproate. 2.